![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | |
A61K 39/40 | |||
A61K 39/21 | |||
A61P 37/00 | |||
C07K 16/28 |
(11) | Number of the document | 2037961 |
(13) | Kind of document | T |
(96) | European patent application number | 07812153.0 |
Date of filing the European patent application | 2007-06-14 | |
(97) | Date of publication of the European application | 2009-03-25 |
(45) | Date of publication and mention of the grant of the patent | 2015-11-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2007/071275 |
Date | 2007-06-14 |
(87) | Number | WO 2007/147090 |
Date | 2007-12-21 |
(30) | Number | Date | Country code |
813903 P | 2006-06-14 | US | |
871361 P | 2006-12-21 | US |
(72) |
KOENIG, Scott, US
WILDER, Ronald, US
BONVINI, Ezio, US
JOHNSON, Leslie, S., US
PILLEMER, Stanley, US
|
(73) |
MacroGenics, Inc.,
1500 East Gude Drive, Rockville, MD 20850-5307,
US
|
(54) | METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS USING MONOCLONAL ANTIBODIES WITH REDUCED TOXICITY |
METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS USING MONOCLONAL ANTIBODIES WITH REDUCED TOXICITY |